ArticleThe Journal of clinical investigation2021

Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination-deficient cancer models.

Manal Mehibel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.